Department of Endocrinology, Tenri Hospital, Nara, Japan; Department of Epidemiology and Healthcare Research, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.
Department of General Medicine, Zablocki VA Medical Center, Milwaukee, WI, USA.
Metabolism. 2014 Mar;63(3):431-40. doi: 10.1016/j.metabol.2013.08.018. Epub 2013 Nov 23.
C-reactive protein (CRP), inflammatory cytokines, and adipokines contribute to atherosclerosis, insulin resistance, and development of late-onset complication in patients with type 2 diabetes. We performed a systematic review to assess effects of exercise interventions on inflammatory markers/cytokines and adipokines.
MATERIALS/METHODS: We searched electronic databases (MEDLINE, EMBASE, and Cochrane Controlled Trials Registry) and reference lists in relevant papers for articles published in 1966-2013. We selected studies that evaluated the effects of exercise intervention on inflammatory markers/cytokines and adipokines in adult patients with type 2 diabetes. Weighted mean differences of exercise on outcomes were derived using fixed or random effect models; factors influencing heterogeneity were identified using meta-regression analysis.
Fourteen randomized controlled trials (824 patients) were included in our meta-analysis. Exercise was associated with a significant in CRP=-0.66mg/l (95% CI, -1.09 to -0.23mg/l; -14% from baseline) and interleukin-6 (IL-6)=-0.88pg/ml (95% CI, -1.44 to -0.32pg/ml; -18% from baseline) but did not alter adiponectin or resistin levels; aerobic exercise program was associated with a significant change in leptin=-3.72ng/ml (95% CI, -6.26 to -1.18ng/ml; -24% from baseline). For IL-6, exercise was more effective in those with a longer duration in the program and larger number of sessions during study (p=0.001).
Exercise decreases inflammatory cytokine (CRP and IL-6) in patients with type 2 diabetes. Exercise could be a therapeutic option for improving abnormalities in inflammation levels in patients with diabetes.
C 反应蛋白(CRP)、炎性细胞因子和脂肪因子会导致 2 型糖尿病患者发生动脉粥样硬化、胰岛素抵抗和出现迟发性并发症。我们进行了一项系统评价,以评估运动干预对炎性标志物/细胞因子和脂肪因子的影响。
材料/方法:我们检索了电子数据库(MEDLINE、EMBASE 和 Cochrane 对照试验注册库)和相关文献的参考文献列表,以获取 1966 年至 2013 年发表的文章。我们选择了评估运动干预对 2 型糖尿病成年患者炎性标志物/细胞因子和脂肪因子影响的研究。使用固定或随机效应模型得出运动对结果的加权均数差;使用荟萃回归分析确定影响异质性的因素。
共有 14 项随机对照试验(824 例患者)纳入本荟萃分析。运动与 CRP 显著降低=-0.66mg/l(95%CI,-1.09 至-0.23mg/l;-14%来自基线)和白细胞介素-6(IL-6)=-0.88pg/ml(95%CI,-1.44 至-0.32pg/ml;-18%来自基线)有关,但不改变脂联素或抵抗素水平;有氧运动方案与瘦素显著变化=-3.72ng/ml(95%CI,-6.26 至-1.18ng/ml;-24%来自基线)有关。对于 IL-6,运动在方案持续时间较长和研究期间的疗程较多的患者中更有效(p=0.001)。
运动可降低 2 型糖尿病患者的炎性细胞因子(CRP 和 IL-6)。运动可能是改善糖尿病患者炎症水平异常的一种治疗选择。